We also found that TI17 inhibited the growth of MM cells in a dose‐dependent manner, while overexpression of TRIP13 increased sensitivity to TI17 as detected by CCK8 kit assays (Figure 1F,G). Here, TRIP13 is linked to Miyoshi myopathy.